because you are expecting way more than what they can provide. The trial is running so effective so long that everyone is living longer and the events are not hitting the set endpoints that fast. what they can do. Believe it or not, this is not chemo or radiation that they are just now reaching the interim analysis and we are going to see the mPFS and that too looks like blinded or most possibly semi blinded just to retain the integrity of the ever forming long tail OS. That's all the Company got and that's all they can provide now, imo, because the therapy is working super good, imo. If you expect more, it is your problem, imo. I'm holding my golden nuggets and adding more whenever I can and just sit tight waiting patiently. Looks like if you tweak this therapy masterfully, you may reach a complete Cure in a field where a mere 2 month of extending the survival is a big deal.
Market Data 
Markets 
AI
